Suchergebnisse - "Laterre, Pierre-François"

PubPharm (471)

1

Understanding the nebulisation of antibiotics : the key role of lung microdialysis studies

enthalten in: Critical care (London, England) | 2024

von Dhanani, J. | Roberts, J. | Monsel, A. | +49

2

The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia : A randomized clinical trial

enthalten in: Journal of critical care | 2024

von Laterre, P. | Sánchez García, M. | van der Poll, T. | +12

3

Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Ngougni Pokem, P. | Liu, X. | Parker, S. | +8

4

Convalescent Plasma for Covid-19-Induced ARDS. Reply

enthalten in: The New England journal of medicine | 2024

von Misset, B. | Desmecht, D. | Laterre, P.

CommentOn: N Engl J Med. 2023 Oct 26;389(17):1590-1600. - PMID 37889107

5

Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing : A Prospective Clinical Exploratory Trial

enthalten in: Antibiotics (Basel, Switzerland) | 2024

von Verroken, A. | Favresse, J. | Anantharajah, A. | +3

6

Inhaled drug delivery : a randomized study in intubated patients with healthy lungs

enthalten in: Annals of intensive care | 2023

von Dugernier, J. | Le Pennec, D. | Maerckx, G. | +14

7

Inhaled drug delivery: a randomized study in intubated patients with healthy lungs

enthalten in: Annals of intensive care | 2023

von Dugernier, J. | Le Pennec, D. | Maerckx, G. | +14

8

Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients

enthalten in: The New England journal of medicine | 2023

von Misset, B. | Piagnerelli, M. | Hoste, E. | +27

CommentIn: N Engl J Med. 2024 Jan 25;390(4):384-385. - PMID 38265659

9

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial

enthalten in: The Lancet. Respiratory medicine | 2023

von François, B. | Lambden, S. | Fivez, T. | +50

CommentIn: Lancet Respir Med. 2023 Oct;11(10):855-857. - PMID 37269869

10

PROFILE OF LIVER CHOLESTATIC BIOMARKERS FOLLOWING PROLONGED KETAMINE ADMINISTRATION IN PATIENTS WITH COVID-19

enthalten in: ResearchSquare.com | 2023

von Henrie¹, J. | Gerard¹, L. | Declerfayt¹, C. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]